Teneliximab (BMS-224819) is a chimeric monoclonal antibody designed to inhibit the interaction between CD40 and CD40L. This antibody exhibits partial agonist activity, enabling limited signaling through CD40. Additionally, Teneliximab facilitates the depletion of peripheral B cells, making it a valuable tool for research into immune system modulation and potential therapeutic applications targeting B cell-mediated disorders.
Teneliximab (BMS-224819) is a chimeric monoclonal antibody designed to inhibit the interaction between CD40 and CD40L. This antibody exhibits partial agonist activity, enabling limited signaling through CD40. Additionally, Teneliximab facilitates the depletion of peripheral B cells, making it a valuable tool for research into immune system modulation and potential therapeutic applications targeting B cell-mediated disorders.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
